戻る
Connect Biopharma Holdings Ltd (CNTB) 収入
CNTB 株価推移チャート
CNTB 収入
Connect Biopharma Holdings Ltd
$2.72
3.81%
$0.1
終値： Apr 01, 16:00:00 GMT-4
$2.9
6.61%
$0.17
アフターマーケット：Apr 01, 17:42:49 GMT-4
主要データ
前終値
$2.62
始値
$2.66
当日レンジ
$2.59 - $2.9
52週レンジ
$0.51 - $3.82
取引高
222.5K
平均取引高
148.0K
配当利回り
--
1株当たり利益(TTM)
-0.82
時価総額
$161.5M
CNTBとは何ですか？
Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. The company is headquartered in San Diego, California and currently employs 62 full-time employees. The company went IPO on 2021-03-19. The firm is focused on advancing rademikibart, a potentially best-in-class next generation anti-interleukin-4-receptor alpha (IL-4Rα) antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease (COPD). Its lead product candidate, rademikibart, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα) in development for the treatment of atopic dermatitis (AD) and asthma. As an inhibitor of IL-4Rα, rademikibart blocks inflammatory signaling by both IL-4 and IL-13. The firm has completed a global Phase II trial (CBP-201-WW001) of rademikibart in adult patients with moderate-to-severe AD.